| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Rush Alzheimer’s Disease Center and Rush Institute for Healthy Aging (Drs. Wilson, Bennett, Bienias, and Evans) and Departments of Neurological Sciences (Drs. Hui, Wilson, Bennett, and Gilley), Psychology (Dr. Wilson), and Internal Medicine (Drs. Bienias and Evans), Rush–Presbyterian–St. Luke’s Medical Center, Chicago, IL.
Address correspondence and reprint requests to Dr. R.S. Wilson, Rush Alzheimer’s Disease Center, 1645 W. Jackson Blvd., Suite 675, Chicago, IL 60612; e-mail: rwilson{at}rush.edu
Background: Alzheimer’s disease (AD) is associated with increased mortality, but survival in those with the disease varies widely. It is uncertain how much of the variation in survival is due to individual differences in rate of disease progression.
Methods: During a 4-year period, 354 persons with AD underwent annual clinical evaluations that included administration of 17 cognitive function tests, from which global and specific measures of cognitive function were derived. A growth curve approach was used to assess individual rates of cognitive decline and proportional hazards models adjusted for age, sex, and education to examine the associations of baseline level of cognition and rate of cognitive decline with mortality.
Results: During the 4-year study period, 242 persons survived and 112 died. At baseline, the global measure of cognition ranged from -1.68 to 1.36 (mean = 0.03, SD = 0.57), with higher scores indicating better function. Baseline level of cognition was not related to mortality (p = 0.12). Global cognition declined an average of 0.56 unit/year, with substantial heterogeneity (SD = 0.41). To determine mortality risk, persons were divided into quartiles based on rate of cognitive decline and survival contrasted in the quartile with the least decline with survival in each remaining quartile, adjusting for baseline level of cognition. Compared with those with the least decline, risk of death was increased more than threefold in the subgroup with mild decline, more than fivefold in those with moderately rapid decline, and more than eightfold in those with the most rapid decline. Similar results were found after controlling for baseline health and disability and in analyses using specific cognitive function measures.
Conclusion: Mortality in AD is strongly associated with rate of cognitive decline.
Received April 21, 2003. Accepted in final form July 3, 2003.
This article has been cited by other articles:
|
|
 |
|
  J. J. Jalbert, L. A. Daiello, and K. L. Lapane Dementia of the Alzheimer Type Epidemiol. Rev., July 16, 2008; (2008) mxn008v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cosentino, N. Scarmeas, E. Helzner, M. M. Glymour, J. Brandt, M. Albert, D. Blacker, and Y. Stern APOE {varepsilon}4 allele predicts faster cognitive decline in mild Alzheimer disease Neurology, May 6, 2008; 70(19_Part_2): 1842 - 1849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.-H. Tsai, S.-P. Chen, K.-N. Lin, P.-N. Wang, H.-C. Wang, C.-Y. Liu, C.-J. Hong, and H.-C. Liu Survival of Ethnic Chinese With Alzheimer's Disease: A 5-Year Longitudinal Study in Taiwan J Geriatr Psychiatry Neurol, September 1, 2007; 20(3): 172 - 177. [Abstract] [PDF]
|
|
|
|
|
|
D. Bhargava, M. F. Weiner, L. S. Hynan, R. Diaz-Arrastia, and A. M. Lipton Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease. J Geriatr Psychiatry Neurol, June 1, 2006; 19(2): 78 - 82. [Abstract] [PDF]
|
|
|
|
 |
|
 L. C. Lam, N. L. Tang, S. Ma, V. W. Lui, A. S. Chan, P Y Leung, and H. F. Chiu Apolipoprotein epsilon-4 allele and the two-year progression of cognitive function in Chinese subjects with late-onset Alzheimer's disease American Journal of Alzheimer's Disease and Other Dementias, March 1, 2006; 21(2): 92 - 99. [Abstract] [PDF]
|
|
|
|
 |
|
 R. S. Wilson, K. R. Krueger, J. M. Kamenetsky, Y. Tang, D. W. Gilley, D. A. Bennett, and D. A. Evans Hallucinations and Mortality in Alzheimer Disease Am J Geriatr Psychiatry, November 1, 2005; 13(11): 984 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sarazin, Y. Stern, C. Berr, A. Riba, M. Albert, J. Brandt, and B. Dubois Neuropsychological predictors of dependency in patients with Alzheimer disease Neurology, March 22, 2005; 64(6): 1027 - 1031. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Godbolt, L. Cipolotti, H. Watt, N. C. Fox, J. C. Janssen, and M. N. Rossor The Natural History of Alzheimer Disease: A Longitudinal Presymptomatic and Symptomatic Study of a Familial Cohort Arch Neurol, November 1, 2004; 61(11): 1743 - 1748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Rate of Cognitive Decline in AD Is Associated with Mortality Journal Watch Neurology, February 13, 2004; 2004(213): 1 - 1. [Full Text]
|
|
|
|
 |
|
 Other Noteworthy Papers This Week Sci. Aging Knowl. Environ., November 26, 2003; 2003(47): nw160 - 160. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
